Skip to Content

MCR 314 (Lamivudine 300 mg)

Pill with imprint MCR 314 is Gray, Four-sided and has been identified as Lamivudine 300 mg. It is supplied by Appco Pharma LLC.

Lamivudine is used in the treatment of hepatitis b; hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Lamivudine 300 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for MCR 314

Lamivudine

Imprint:
MCR 314
Strength:
300 mg
Color:
Gray
Shape:
Four-sided
Availability:
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Appco Pharma LLC
National Drug Code (NDC):
55801-0314

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide